Zealand Pharma (NASDAQ OMX Copenhagen: ZEAL) (“Zealand”) announces the appointment of Dr Torsten Hoffmann as Executive Vice President and the company’s new Chief Scientific Officer. Torsten joins Zealand with effect from 1 October 2013 from F. Hoffmann-La Roche Ltd (RO:SWX) (“Roche”) where he served as Head of Discovery Chemistry in the Pharma Research division at the company’s headquarters in Basel, Switzerland.
Help employers find you! Check out all the jobs and post your resume.
